Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Characterisation of the Immune Infiltrate and Molecular Features of Thymic Epithelial Tumors Tumors (TETs)

NCT05558644 is registered in ClinicalTrials.gov with Institut Curie as lead sponsor.

NCT NCT05558644
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05558644 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Characterisation of the Immune Infiltrate and Molecular Features of Thymic Epithelial Tumors Tumors (TETs)
Lead sponsor
Institut Curie
Phase
Not applicable
Overall status
Recruiting
Start date
August 3, 2023
Completion date
October 2, 2029
Enrollment
50 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

cancer